Oriva Therapeutics
PrivateLast Round
Pre Seed
Jan 22, 2026
Company Overview
Oriva Therapeutics is a biotechnology company developing therapies for chronic gynecological diseases such as endometriosis and uterine fibroids.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
endometriosis treatmentnon-hormonal therapydisease-modifying therapyclinical-stage biotechuterine fibroids treatmentwomen's healthfemtechdrug developmentfirst-in-class therapyoral therapygynecologybiotech spin-out
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oriva Therapeutics Comparables
Compare Oriva Therapeutics with similar companies based on industry and business-model similarity.
Oriva Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jan 22, 2026 |
Oriva Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Pre Seed |
Oriva Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oriva Therapeutics's valuation, stock price, and market status.